Your session is about to expire
← Back to Search
Dual-Energy CT for Brain Tumor, Lung Cancer, and Brain Metastases
Study Summary
This trial is testing a new way to make proton beam therapy more accurate, by using CT scans with two different energy levels to better understand the tissue the proton beam will travel through.
- Lung Cancer
- Head and Neck Cancers
- Brain Metastases
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had contrast medium through an IV or by mouth within 24 hours before getting a specific type of imaging.You are planning to have radiation therapy for your cancer using proton or photon beams.You have been diagnosed with cancer that needs radiation therapy to the chest, head and neck, or brain.
- Group 1: Dual-Energy CT scan
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there still an opportunity to join this research endeavor?
"Affirmative. Clinicaltrials.gov records demonstrate that this medical experiment, which was initially published on June 1st 2018, is still actively enlisting participants. Approximately 40 patients are required from a single trial site."
What is the current capacity for participants in this trial?
"Affirmative, based on the information posted to clinicaltrials.gov this trial is actively seeking volunteers for participation. First published in June 2018 and most recently edited in October 2022, it requires 40 individuals from one medical facility to partake."
Share this study with friends
Copy Link
Messenger